In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Adenosine Triphosphate Drug Master File in Korea (Adenosine Triphosphate KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Adenosine Triphosphate. The MFDS reviews the Adenosine Triphosphate KDMF as part of the drug registration process and uses the information provided in the Adenosine Triphosphate KDMF to evaluate the safety and efficacy of the drug.
After submitting a Adenosine Triphosphate KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Adenosine Triphosphate API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Adenosine Triphosphate suppliers with KDMF on PharmaCompass.